Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment by Hildesheim, Allan, PhD, Gonzalez, Paula, MD, Kreimer, Aimee R., PhD, Wacholder, Sholom, PhD, Schussler, John, Rodriguez, Ana C., MD, Porras, Carolina, PhD, Schiffman, Mark, MD, Sidawy, Mary, MD, Schiller, John T., PhD, Lowy, Douglas R., MD, Herrero, Rolando, MD

Get full text

Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial by Kreimer, Aimée R, Dr, González, Paula, MD, Katki, Hormuzd A, PhD, Porras, Carolina, MS, Schiffman, Mark, MD, Rodriguez, Ana Cecilia, MD, Solomon, Diane, MD, Jiménez, Silvia, MS, Schiller, John T, PhD, Lowy, Douglas R, MD, van Doorn, Leen-Jan, PhD, Struijk, Linda, PhD, Quint, Wim, PhD, Chen, Sabrina, BS, Wacholder, Sholom, PhD, Hildesheim, Allan, PhD, Herrero, Rolando, MD

Get full text

Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging by Lowy, Douglas R, Dr, Herrero, Rolando, MD, Hildesheim, Allan, PhD

Get full text

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials by Kreimer, Aimée R, Dr, Struyf, Frank, MD, Del Rosario-Raymundo, Maria Rowena, MD, Hildesheim, Allan, Prof, Skinner, S Rachel, PhD, Wacholder, Sholom, Prof, Garland, Suzanne M, Prof, Herrero, Rolando, PhD, David, Marie-Pierre, MSc, Wheeler, Cosette M, Dr Prof

Get full text

Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptor by Roden, R.B.S. (National Cancer Institute, Bethesda, MD.), Hubbert, N.L, Kirnbauer, R, Breitburd, F, Lowy, D.R, Schiller, J.T

Get full text